ClinicalTrials.gg
RecruitingNCT07882082Updated Oct 20, 2026

Analysis of Electroencephalogram (EEG) Changes in Subacute Stroke Patients

An observational study in Stroke and Electroencephalogram (EEG), sponsored by Bundang CHA Hospital. Recruiting at 1 site in South Korea. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Bundang CHA Hospital · Observational

From the registry’s dates

  • Started Apr 2021; still recruiting 5 years 6 months later.
Updated Oct 20, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
20 Years and older
Sex
All
01

Study summary

This study aims to examine how electroencephalogram (EEG) measures change over time in patients with stroke and to compare EEG measures according to the location of brain injury. Associations between EEG measures, function, and brain activity will also be analyzed.

Read the detailed description

This observational study will enroll 200 patients with stroke aged 20 years or older. Participants will undergo an initial EEG assessment and up to four follow-up assessments, with fNIRS measured alongside EEG. EEG measures will be compared by brain lesion location and analyzed in relation to functional assessments and brain activity. Follow-up data will be used to examine correlations between functional improvement and changes in EEG waveforms.

02

Conditions studied

  • Stroke
  • Electroencephalogram (EEG)

Browse trials for

Keywords

  • Electroencephalogram (EEG)
  • Functional Near-Infrared Spectroscopy (fNIRS)
03

In context

Stroke

7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's planned enrollment of 200 is above the median of 160 across 1,729 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Bundang CHA Hospital is the lead sponsor of 35 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adult stroke patients (aged 20 years or older) recruited from the Department of Rehabilitation Medicine. Participants include patients in the subacute to chronic recovery phases. Eligibility requires a stable clinical condition suitable for serial Electroencephalogram (EEG) recordings and all required clinical assessments, and the provision of written informed consent. Patients deemed clinically unsuitable by the investigator will be excluded

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients, male or female, aged 20 years or older.
  • Diagnosed with stroke (ischemic or hemorrhagic) and transferred to the Department of Rehabilitation Medicine
  • In a stable condition that permits Electroencephalogram (EEG) acquisition
  • The patient or their legally authorized representative has fully understood the details of this clinical study, voluntarily decided to participate, and provided written informed consent

Exclusion criteria

Exclusion Criteria:

- Any case determined by the investigator to be unsuitable for participation in the clinical study

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Stroke Patients

    Patients with stroke aged 20 years or older who have been transferred to the Department of Rehabilitation Medicine and are able to undergo EEG assessment. Participants will undergo an initial EEG assessment and up to four follow-up assessments, with fNIRS measured alongside EEG.

06

What researchers measure

Primary outcomes

  1. EEG spectral power

    Spectral power across EEG frequency bands will be measured and compared by brain lesion location and over time. Associations with functional assessments and brain activity will also be analyzed.

    Time frame: Baseline and up to 5 years

Secondary outcomes

  1. Cerebral oxygenated hemoglobin concentration measured using fNIRS

    Cerebral oxygenated hemoglobin concentration will be measured using functional near-infrared spectroscopy (fNIRS) to assess brain activity.

    Time frame: Baseline and up to 5 years

07

Study locations

1 of 1 sites recruiting
  • Bundang CHA Hospital
    Seongnam-si, Gyeonggi-do 13496, South Korea
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07882082
Lead sponsor
Bundang CHA Hospital
Responsible party
MinYoung Kim, MD, PhD (Principle Investigator, Bundang CHA Hospital) — Principal investigator
First posted
Oct 20, 2026
Start date
Apr 21, 2021
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Oct 20, 2026

Study contacts

Yubin Kim
Contact
a240285@chamc.co.kr
+82-31-780-6003
Minyoung Kim, M.D., Ph.D
principal investigator · Bundang CHA Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion